✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › Paritaprevir

Paritaprevir

CAS 1216941-48-8C40H43N7O7SMW 765.9

Paritaprevir (CAS 1216941-48-8) — formula C40H43N7O7S, molecular weight 765.9; category organic chemicals.

Product Overview

CAS Number1216941-48-8
Molecular FormulaC40H43N7O7S
Molecular Weight765.9
LogP4.7
CategoryOrganic Chemicals

Technical Profile

What this product is

Paritaprevir is a carbon-based organic compound with CAS registry number 1216941-48-8 and molecular formula C40H43N7O7S (molecular weight 765.9), belonging to the organic chemicals segment of chemical raw materials.

Identification

CAS number: 1216941-48-8

Its molecular formula C40H43N7O7S comprises 40 C, 43 H, 7 N, 7 O, 1 S atoms.

Also known as: Paritaprevir · 帕瑞瑞韦

Category: organic chemicals

Frequently Asked Questions

What is the CAS number of Paritaprevir?

The CAS registry number of Paritaprevir is 1216941-48-8.

What is the molecular formula and molecular weight of Paritaprevir?

Molecular formula C40H43N7O7S, molecular weight 765.9.

What other names is Paritaprevir known by?

It is also registered under: Paritaprevir, 帕瑞瑞韦.

Which category does Paritaprevir belong to?

Category: Organic Chemicals.

PubChem Public Data

Independent reference data for Paritaprevir (CAS 1216941-48-8), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number1216941-48-8
PubChem CID45110509
Molecular formulaC40H43N7O7S
IUPAC name(1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-[(5-methylpyrazine-2-carbonyl)amino]-2,15-dioxo-18-phenanthridin-6-yloxy-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide
UNII (FDA)OU2YM37K86

Computed descriptors

Molecular Weight765.9
XLogP34.7
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count10
Rotatable Bond Count7
Exact Mass765.29446791
Monoisotopic Mass765.29446791
Topological Polar Surface Area198
Heavy Atom Count55

Documented uses on record

    When used within the fixed-dose combination product with [DB09296], [DB09183], and [DB00503] as the FDA-approved product Viekira Pak, paritaprevir is indicated for the treatment of HCV genotype 1b without cirrhosis or with compensated cirrhosis, and when combined with [DB00811] for the treatment of HCV genotype 1a without cirrhosis or with compensated cirrhosis. When used within the fixed-dose combination product with [DB09296] and [DB00503] as the FDA- and Health Canada-approved product Technivie, paritaprevir isBreast Feeding; Lactation; Milk, Human; Antiviral Agents; Protease Inhibitors

    Synonyms and trade names

    Paritaprevir; 1216941-48-8; Veruprevir; ABT-450; Veruprevir anhydrous; ABT450; OU2YM37K86; ABT 450; DTXSID601027922; VIEKIRAX COMPONENT PARITAPREVIR; CHEBI:85188; empty; paritaprevirum; RefChem:170090; DTXCID501513483; 1221573-85-8

    What the public record says

    Paritaprevir · CAS 1216941-48-8 · C40H43N7O7S. UNII OU2YM37K86.

    Physical description and handling notes

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 帕瑞瑞韦

鲁ICP备19031700号-2